Universidade Federal de Sergipe   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Sergipe Brazil (1967)

Organization Overview

First Clinical Trial
2012
NCT01948622
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

André Luis Faria e Silva | Flavia Pardo Salata Nahsan | Johnny Alexandre Oliveira Tavares | Liane Maciel de Almeida Souza | Universidade Federal de Sergipe

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anxiety Disorders (Phase 2)

Dentin Sensitivity (Phase 3)

Hypersensitivity (Phase 4)

Toothache (Phase 3)

Tooth Discoloration (Phase 4)

Tooth, Impacted (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 10